Authors


Antony Loebel, MD

Latest:

2020 and Beyond Will Bring Significant Progress in Addressing Mental Illness

Progress has been made in developing new approaches for patients with serious mental health conditions.


Dana Edwards

Latest:

Critical Connection: Patient Services and Product Launch

A look at best-practice approaches to aligning the strategy and design of hub service models with preparations for market entry of a new therapy.


Casey Horton

Latest:

Critical Connection: Patient Services and Product Launch

A look at best-practice approaches to aligning the strategy and design of hub service models with preparations for market entry of a new therapy.


Janardhan Vellore and Daniel Wetherill

Latest:

Prescribing Patterns: How to Get Ahead of the Trends

The key to success in a hypercompetitive marketplace is to create targeting plans that get ahead of tomorrow’s prescriptions.


Melissa Dimitri, Larry Smith, Laurel Fitts, Mark Trybulski

Latest:

Towards a Multichannel Marketing Culture

The biggest challenge to becoming a multi-channel marketing organization is not a company's technology, it’s the culture, write Melissa Dimitri, Larry Smith, Laurel Fitts, and Mark Trybulski.


Cliodhna McDonough

Latest:

The Brexit Deal and the Life Sciences Sector

On December 24, 2020, the UK finally agreed a Trade and Cooperation Agreement (TCA) with the EU. Cliodhna McDonough offers some initial thoughts on the implications of the TCA on the life sciences sector.


Kal Patel

Latest:

Transforming the CIO Role to Embrace Digital Health

Strategies for those chief information officers taking the digital reins at their organizations.


Richard Gliklich, MD

Latest:

Forget Selecting a Site — Now the Site Selects You

Post-approval studies, at many companies, do not have a consistent strategy that builds networks of investigators.


Wolfram Lux and Simone Seiter

Latest:

Commercializing an Orphan Drug: Why “Just” Serving a High Unmet Medical Need Won’t Do the Job

Looking at four building blocks of success, Wolfram Lux and Simone Seiter investigate what it takes to win and be successful when commercializing an orphan drug


Don Steele

Latest:

A Contingent Workforce Strategy Is Critical to Life Sciences Companies

Speed to market is crucial to the success of launching new products and therapies.



Anita Moser, Michael Davis, Dharmendra Sahay

Latest:

How UCB Transformed into a More Agile, Data-Driven Organization

Anita Moser, Michael Davis, Dharmendra Sahay outline UCB's measured approach to scaling its AI capabilities.


Wuraola Oladokun and Yvonne Ellis-Clarke

Latest:

Lean Thinking in Life Sciences: A Case for Enabling People

Fully understanding the construct of what it means to be lean can equip individual contributors, teams, and leaders to contribute to the fullest extent of their capabilities.



Rob Besse

Latest:

What You Need to Know about the Drug Supply Chain Security Act

It is vital to begin asking questions about your company’s DSCSA readiness and compliance, as well as that of your strategic partners, writes Rob Besse.


Suzanne Bates

Latest:

Leading Teams through the COVID-19 Crisis

Suzanne Bates offers advice for leaders who are steering their teams through the current health crisis.


Anand Kiran

Latest:

Digital Upskilling

Archaic ways of working need to make way for more agile and nimble response mechanisms enabled by a systematic enterprise-wide digital upskilling strategy, writes Anand Kiran.


Ilya Vedrashko and Parag More

Latest:

Design Thinking in Multichannel Marketing

While marketers must work with less than perfect insight when devising their channel strategies, they can improve their success rate by applying Design Thinking, write Ilya Vedrashko and Parag More.



Cognizant, Brand Insights Contributor

Latest:

COVID-19 Highlights Need for More Agility, New Paradigms in Drug Development

The rapid spread of COVID-19 across the globe highlights the absolute need for preparedness in the face of pandemics in order to reduce and eliminate the emergence of new cases and quickly create treatment options for emerging illnesses and diseases.



Sarah Jarvis

Latest:

How Medical Affairs Teams Need to Adapt to COVID-19

COVID-19 will cause acute strain on medical affairs in the short term, but longer-term planning is also needed to ensure that teams can remain in the more visible role that customers are demanding, writes Sarah Jarvis.


Datacubed Health

Latest:

Patient Experience Breakthroughs: Leveraging the Latest Digital Tools and Techniques to Optimize your Patient Experience Goals

Learn how breakthrough patient experience strategies can help achieve your study goals in this upcoming webcast. Lead by renowned neuroscientist and behavioral economist Dr. Paul Glimcher, it’s the one webcast this year your team can’t afford to miss. Live: Tuesday, May 19, 2020 at 1pm EDT | 12pm CDT | 10am PDT On demand available after airing until May 19, 2021. Register free





Andy Pyfer, Brand Insights Contributor, Partner, Fingerpaint

Latest:

Solving Access Challenges in Today’s Market

New drug launches face more marketplace scrutiny today than a decade ago. Brand success requires not only communicating the clinical value to providers and patients, but also demonstrating the cost-effectiveness to payers in a real-world setting.




Joe G.N. Garcia, MD

Latest:

Fight Against COVID-19 May Yield Solutions to ARDS

Combating ARDS, the biggest threat to COVID-19 patients, may lead to new treatments for the condition, writes physician and biotech CEO Joe G. N. “Skip” Garcia.